Why McKesson (MCK) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, McKesson (MCK) closed at $599.56, marking a -0.8% move from the previous day.
McKesson (MCK) Reaches 52-Week High: What's Aiding the Stock?
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know
In the most recent trading session, McKesson (MCK) closed at $603.24, indicating a +0.05% shift from the previous trading day.
McKesson (MCK) Introduces FDA-Approved Prostate Cancer Drug
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients improved treatment options for prostate cancer.
McKesson (MCK) Sees a More Significant Dip Than Broader Market: Some Facts to Know
McKesson (MCK) closed at $589.95 in the latest trading session, marking a -0.19% move from the prior day.
McKesson (MCK) Laps the Stock Market: Here's Why
The latest trading day saw McKesson (MCK) settling at $591.07, representing a +1.07% change from its previous close.
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson (MCK) Gains 26% YTD: What's Driving the Rally?
McKesson's (MCK) shares have risen year to date on the back of strong fundamentals. Rising volumes of prescription and specialty drugs boost the top line.
McKesson is a Growing Giant
McKesson Corporation (MCK) is poised to grow due to an aging population and expanding Type 2 diabetes treatments.
Here's Why You Should Hold McKesson (MCK) in Your Portfolio Now
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
